Author

Garrett Lam

Broad Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Bryce OrdwayiD· 1 shared Chenxu GuoiD· 1 shared Eric F. ZaniewskiiD· 1 shared Esther RheinbayiD· 1 shared Gary X. WangiD· 1 shared Ilze SmidtiD· 1 shared Ioannis SanidasiD· 1 shared Kazi Nazrul Islam· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bryce OrdwayORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A SIRT5-induced metabolic switch underlies chemoresistance and ATR checkpoint dependence in triple-negative breast cancer

Zuen Ren, Tiziano Bernasocchi, Kiran Kurmi, Chenxu Guo, Kevin Jiang, Eric F. Zaniewski, Garrett Lam, Kazi Nazrul Islam, Shakchhi Joshi, Xin Li, Ilze Smidt, Robert Morris, Bryce Ordway, Veerle Bossuyt, Gary X. Wang, , Leif William Ellisen

This study identifies SIRT5-induced metabolic changes as a driver of chemoresistance in TNBC and reveals ATR checkpoint dependence as a therapeutic vulnerability.

bioRxiv · Apr 9, 2026 · PreprintCancer Biology